Glucagon-like peptide-2 activates β-catenin signaling in the mouse intestinal crypt: Role of insulin-like growth factor-I

Endocrinology

Volumn 149, Issue 1, 2008, Pages 291-301

  Dubé, Philip E ^a   Rowland, Katherine J ^a   Brubaker, Patricia L ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; CASPASE 3; GLUCAGON LIKE PEPTIDE 2; GLYCOGEN SYNTHASE KINASE 3BETA; MYC PROTEIN; NVP AEW 541; PROTEIN KINASE B; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; TEDUGLUTIDE; TRANSCRIPTION FACTOR SOX9;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL NUCLEUS; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIET RESTRICTION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FEMALE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; INTESTINE CRYPT; INTESTINE EPITHELIUM; INTESTINE MUCOSA; INTRACELLULAR TRANSPORT; KNOCKOUT MOUSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN TARGETING; PROTEIN TRANSPORT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

ANIMALS; BETA CATENIN; FASTING; FEMALE; GLUCAGON-LIKE PEPTIDE 2; HIGH MOBILITY GROUP PROTEINS; INSULIN-LIKE GROWTH FACTOR I; INTESTINAL MUCOSA; KI-67 ANTIGEN; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROVILLI; MODELS, BIOLOGICAL; ONCOGENE PROTEIN V-AKT; PYRIMIDINES; PYRROLES; RECEPTOR, IGF TYPE 1; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS;

EID: 37549001395     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2007-0561     Document Type: Article

References (69)

1. Drucker DJ, Erlich P, Asa SL, Brubaker PL 1996 Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc Natl Acad Sci USA 93:7911-7916
2. Tsai CH, Hill M, Asa SL, Brubaker PL, Drucker DJ 1997 Intestinal growth-promoting properties of glucagon-like peptide-2 in mice. Am J Physiol Endocrinol Metab 273:E77-E84
3. Litvak DA, Hellmich MR, Evers BM, Banker NA, Townsend Jr CM 1998 Glucagon-like peptide 2 is a potent growth factor for small intestine and colon. J Gastrointest Surg 2:146-150
4. Burrin DG, Stoll B, Guan X, Cui L, Chang X, Holst JJ 2005 Glucagon-like peptide 2 dose-dependently activates intestinal cell survival and proliferation in neonatal piglets. Endocrinology 146:22-32
5. Cheeseman CI, Tsang R 1996 The effect of GIP and glucagon-like peptides on intestinal basolateral membrane hexose transport. Am J Physiol Gastrointest Liver Physiol 271:G477-G482
6. Brubaker PL, Izzo A, Hill M, Drucker DJ 1997 Intestinal function in mice with small bowel growth induced by glucagon-like peptide-2. Am J Physiol Endocrinol Metab 272:E1050-E1058
7. Boushey RP, Yusta B, Drucker DJ 1999 Glucagon-like peptide 2 decreases mortality and reduces the severity of indomethacin-induced murine enteritis. Am J Physiol Endocrinol Metab 277:E937-E947
8. Sigalet DL, Wallace LE, Holst JJ, Martin GR, Kaji T, Tanaka H, Sharkey KA 2007 Enteric neural pathways mediate the anti-inflammatory actions of glucagon-like peptide 2. Am J Physiol Gastrointest Liver Physiol 293:G211-G221
9. Guan X, Stoll B, Lu X, Tappenden KA, Holst JJ, Hartmann B, Burrin DG 2003 GLP-2-mediated up-regulation of intestinal blood flow and glucose uptake is nitric oxide-dependent in TPN-fed piglets 1. Gastroenterology 125:136-147
10. Tavares W, Drucker DJ, Brubaker PL 2000 Enzymatic- and renal-dependent catabolism of the intestinotropic hormone glucagon-like peptide-2 in rats. Am J Physiol Endocrinol Metab 278:E134-E139
11. Drucker DJ, Shi Q, Crivici A, Sumner-Smith M, Tavares W, Hill M, DeForest L, Cooper S, Brubaker PL 1997 Regulation of the biological activity of glucagon-like peptide 2 in vivo by dipeptidyl peptidase IV. Nat Biotechnol 15:673-677
12. Drucker DJ, Yusta B, Boushey RP, DeForest L, Brubaker PL 1999 Human [Gly2]GLP-2 reduces the severity of colonic injury in a murine model of experimental colitis. Am J Physiol Gastrointest Liver Physiol 276:G79-G91
13. Scott RB, Kirk D, MacNaughton WK, Meddings JB 1998 GLP-2 augments the adaptive response to massive intestinal resection in rat. Am J Physiol Gastrointest Liver Physiol 275:G911-G921
14. L'Heureux MC, Brubaker PL 2003 Glucagon-like peptide-2 and common therapeutics in a murine model of ulcerative colitis. J Pharmacol Exp Ther 306:347-354
15. Chance WT, Foley-Nelson T, Thomas I, Balasubramaniam A 1997 Prevention of parenteral nutrition-induced gut hypoplasia by coinfusion of glucagon-like peptide-2. Am J Physiol Gastrointest Liver Physiol 273:G559-G563
16. Prasad R, Alavi K, Schwartz MZ 2000 Glucagonlike peptide-2 analogue enhances intestinal mucosal mass after ischemia and reperfusion. J Pediatr Surg 35:357-359
17. Jeppesen PB, Hartmann B, Thulesen J, Graff J, Lohmann J, Hansen BS, Tofteng F, Poulsen SS, Madsen JL, Holst JJ, Mortensen PB 2001 Glucagon-like peptide 2 improves nutrient absorption and nutritional status in short-bowel patients with no colon. Gastroenterology 120:806-815
18. Jeppesen PB, Sanguinetti EL, Buchman A, Howard L, Scolapio JS, Ziegler TR, Gregory J, Tappenden KA, Holst J, Mortensen PB 2005 Teduglutide (ALX-0600), a dipeptidyl peptidase IV resistant glucagon-like peptide 2 analogue, improves intestinal function in short bowel syndrome patients. Gut 54:1224-1231
19. Munroe DG, Gupta AK, Kooshesh F, Vyas TB, Rizkalla G, Wang H, Demchyshyn L, Yang ZJ, Kamboj RK, Chen H, McCallum K, Sumner-Smith M, Drucker DJ, Crivici A 1999 Prototypic G protein-coupled receptor for the intestinotrophic factor glucagon-like peptide 2. Proc Natl Acad Sci USA 96:1569-1573
20. Yusta B, Huang L, Munroe D, Wolff G, Fantaske R, Sharma S, Demchyshyn L, Asa SL, Drucker DJ 2000 Enteroendocrine localization of GLP-2 receptor expression in humans and rodents. Gastroenterology 119:744-755
21. Bjerknes M, Cheng H 2001 Modulation of specific intestinal epithelial progenitors by enteric neurons. Proc Natl Acad Sci USA 98:12497-12502
22. Orskov C, Hartmann B, Poulsen SS, Thulesen J, Hare KJ, Holst JJ 2005 GLP-2 stimulates colonic growth via KGF, released by subepithelial myofibroblasts with GLP-2 receptors. Regul Pept 124:105-112
23. Guan X, Karpen HE, Stephens J, Bukowski JT, Niu S, Zhang G, Stoll B, Finegold MJ, Holst JJ, Hadsell D, Nichols BL, Burrin DG 2006 GLP-2 receptor localizes to enteric neurons and endocrine cells expressing vasoactive peptides and mediates increased blood flow. Gastroenterology 130:150-164
24. Nelson DW, Sharp JW, Brownfield MS, Raybould HE, Ney DM 2007 Localization and activation of glucagon-like peptide-2 receptors on vagal afferents in the rat. Endocrinology 148:1954-1962
25. Dubé PE, Forse CL, Bahrami J, Brubaker PL 2006 The essential role of insulin-like growth factor-1 in the intestinal tropic effects of glucagon-like peptide-2 in mice. Gastroenterology 131:589-605
26. Lund PK 1999 IGFs and the digestive tract. In: Roberts CT, Rosenfeld RG, eds. The IGF system: molecular biology, physiology, and clinical applications. Totowa, NJ: Humana Press; 517-544
27. Dahly EM, Guo Z, Ney DM 2003 IGF-I augments resection-induced mucosal hyperplasia by altering enterocyte kinetics. Am J Physiol Regul Integr Comp Physiol 285:R800-R808
28. Read LC, Tomas FM, Howarth GS, Martin AA, Edson KJ, Gillespie CM, Owens PC, Ballard FJ 1992 Insulin-like growth factor-I and its N-terminal modified analogues induce marked gut growth in dexamethasone-treated rats. J Endocrinol 133:421-431
29. Potten CS, Owen G, Hewitt D, Chadwick CA, Hendry H, Lord BI, Woolford LB 1995 Stimulation and inhibition of proliferation in the small intestinal crypts of the mouse after in vivo administration of growth factors. Gut 36:864-873
30. Drucker DJ, DeForest L, Brubaker PL 1997 Intestinal response to growth factors administered alone or in combination with human [Gly2]glucagon-like peptide 2. Am J Physiol Gastrointest Liver Physiol 273:G1252-G1262
31. Ney DM, Huss DJ, Gillingham MB, Kritsch KR, Dahly EM, Talamantez JL, Adamo ML 1999 Investigation of insulin-like growth factor (IGF)-I and insulin receptor binding and expression in jejunum of parenterally fed rats treated with IGF-I or growth hormone. Endocrinology 140:4850-4860
32. Gregorieff A, Clevers H 2005 Wnt signaling in the intestinal epithelium: From endoderm to cancer. Genes Dev 19:877-890
33. Brembeck FH, Rosario M, Birchmeier W 2006 Balancing cell adhesion and Wnt signaling, the key role of β-catenin. Curr Opin Genet Dev 16:51-59
34. Scheid MP, Woodgett JR 2001 PKB/AKT: functional insights from genetic models. Nat Rev Mol Cell Biol 2:760-768
35. Sheng H, Shao J, Townsend Jr CM, Evers BM 2003 Phosphatidylinositol 3-kinase mediates proliferative signals in intestinal epithelial cells. Gut 52:1472-1478
36. Burrin DG, Stoll B, Guan X, Cui L, Chang X, Hadsell D 2007 GLP-2 rapidly activates divergent intracellular signaling pathways involved in intestinal cell survival and proliferation in neonatal piglets. Am J Physiol Endocrinol Metab 292:E281-E291
37. Playford MP, Bicknell D, Bodmer WF, Macaulay VM 2000 Insulin-like growth factor 1 regulates the location, stability, and transcriptional activity of β-catenin. Proc Natl Acad Sci USA 97:12103-12108
38. Desbois-Mouthon C, Cadoret A, Blivet-Van Eggelpoel MJ, Bertrand F, Cherqui G, Perret C, Capeau J 2001 Insulin and IGF-I stimulate the β-catenin pathway through two signalling cascades involving GSK-3β inhibition and Ras activation. Oncogene 20:252-259
39. Ding Q, Xia W, Liu JC, Yang JY, Lee DF, Xia J, Bartholomeusz G, Li Y, Pan Y, Li Z, Bargou RC, Qin J, Lai CC, Tsai FJ, Tsai CH, Hung MC 2005 Erk associates with and primes GSK-3β for its inactivation resulting in upregulation of β-catenin. Mol Cell 19:159-170
40. Chen J, Wu A, Sun H, Drakas R, Garofalo C, Cascio S, Surmacz E, Baserga R 2005 Functional significance of type 1 insulin-like growth factor-mediated nuclear translocation of the insulin receptor substrate-1 and β-catenin. J Biol Chem 280:29912-29920
41. Garcia-Echeverria C, Pearson MA, Marti A, Meyer T, Mestan J, Zimmermann J, Gao J, Brueggen J, Capraro HG, Cozens R, Evans DB, Fabbro D, Furet P, Porta DG, Liebetanz J, Martiny-Baron G, Ruetz S, Hofmann F 2004 In vivo antitumor activity of NVP-AEW541-A novel, potent, and selective inhibitor of the IGF-IR kinase. Cancer Cell 5:231-239
42. Scotlandi K, Manara MC, Nicoletti G, Lollini PL, Lukas S, Benini S, Croci S, Perdichizzi S, Zambelli D, Serra M, Garcia-Echeverria C, Hofmann F, Picci P 2005 Antitumor activity of the insulin-like growth factor-I receptor kinase inhibitor NVP-AEW541 in musculoskeletal tumors. Cancer Res 65:3868-3876
43. Powell-Braxton L, Hollingshead P, Warburton C, Dowd M, Pitts-Meek S, Dalton D, Gillett N, Stewart TA 1993 IGF-I is required for normal embryonic growth in mice. Genes Dev 7:2609-2617
44. Shin ED, Estall JL, Izzo A, Drucker DJ, Brubaker PL 2005 Mucosal adaptation to enteral nutrients is dependent on the physiologic actions of glucagon-like peptide-2 in mice. Gastroenterology 128:1340-1353
45. Francis GL, Ross M, Ballard FJ, Milner SJ, Senn C, McNeil KA, Wallace JC, King R, Wells JR 1992 Novel recombinant fusion protein analogues of insulin-like growth factor (IGF)-I indicate the relative importance of IGF-binding protein and receptor binding for enhanced biological potency. J Mol Endocrinol 8:213-223
46. Anini Y, Brubaker PL 2003 Role of leptin in the regulation of glucagon-like peptide-1 secretion. Diabetes 52:252-259
47. Pfaffl MW 2001 A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res 29:e45
48. Batlle E, Henderson JT, Beghtel H, van den Born MM, Sancho E, Huls G, Meeldijk J, Robertson J, van de Wetering M, Pawson T, Clevers H 2002 β-Catenin and TCF mediate cell positioning in the intestinal epithelium by controlling the expression of EphB/ephrinB. Cell 111:251-263
49. van Es JH, Jay P, Gregorieff A, van Gijn ME, Jonkheer S, Hatzis P, Thiele A, van den Born M, Begthel H, Brabletz T, Taketo MM, Clevers H 2005 Wnt signalling induces maturation of Paneth cells in intestinal crypts. Nat Cell Biol 7:381-386
50. Pinto D, Gregorieff A, Begthel H, Clevers H 2003 Canonical Wnt signals are essential for homeostasis of the intestinal epithelium. Genes Dev 17:1709-1713
51. Muncan V, Sansom OJ, Tertoolen L, Phesse TJ, Begthel H, Sancho E, Cole AM, Gregorieff A, de Alboran IM, Clevers H, Clarke AR 2006 Rapid loss of intestinal crypts upon conditional deletion of the Wnt/Tcf-4 target gene c-Myc. Mol Cell Biol 26:8418-8426
52. Blache P, van de Wetering M, Duluc I, Domon C, Berta P, Freund JN, Clevers H, Jay P 2004 SOX9 is an intestine crypt transcription factor, is regulated by the Wnt pathway, and represses the CDX2 and MUC2 genes. J Cell Biol 166:37-47
53. Cheeseman CI 1997 Upregulation of SGLT-1 transport activity in rat jejunum induced by GLP-2 infusion in vivo. Am J Physiol Regul Integr Comp Physiol 273:R1965-R1971
54. Alessi DR, Andjelkovic M, Caudwell B, Cron P, Morrice N, Cohen P, Hemmings BA 1996 Mechanism of activation of protein kinase B by insulin and IGF-I. EMBO J 15:6541-6551
55. Cross DA, Alessi DR, Cohen P, Andjelkovich M, Hemmings BA 1995 Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature 378:785-789
56. Cardone MH, Roy N, Stennicke HR, Salvesen GS, Franke TF, Stanbridge E, Frisch S, Reed JC 1998 Regulation of cell death protease caspase-9 by phosphorylation. Science 282:1318-1321
57. Staal FJ, Noort Mv M, Strous GJ, Clevers HC 2002 Wnt signals are transmitted through N-terminally dephosphorylated β-catenin. EMBO Rep 3:63-68
58. Thulesen J, Hartmann B, Hare KJ, Kissow H, Orskov C, Holst JJ, Poulsen SS 2004 Glucagon-like peptide 2 (GLP-2) accelerates the growth of colonic neoplasms in mice. Gut 53:1145-1150
59. Stoyanov B, Volinia S, Hanck T, Rubio I, Loubtchenkov M, Malek D, Stoyanova S, Vanhaesebroeck B, Dhand R, Nurnberg B, Gierschik P, Seedorf K, Hsuan JJ, Waterfield MD, Wetzker R 1995 Cloning and characterization of a G protein-activated human phosphoinositide-3 kinase. Science 269:690-693
60. Tessier M, Woodgett JR 2006 Serum and glucocorticoid-regulated protein kinases: variations on a theme. J Cell Biochem 98:1391-1407
61. Walsh NA, Yusta B, DaCambra MP, Anini Y, Drucker DJ, Brubaker PL 2003 Glucagon-like peptide-2 receptor activation in the rat intestinal mucosa. Endocrinology 144:4385-4392
62. Al-Nafussi AI, Wright NA 1982 The effect of epidermal growth factor (EGF) on cell proliferation of the gastrointestinal mucosa in rodents. Virchows Arch B Cell Pathol Incl Mol Pathol 40:63-69
63. Dignass AU, Sturm A 2001 Peptide growth factors in the intestine. Eur J Gastroenterol Hepatol 13:763-770
64. Wood JG, Hoang HD, Bussjaeger LJ, Solomon TE 1988 Neurotensin stimulates growth of small intestine in rats. Am J Physiol 255:G813-G817
65. Evers BM, Izukura M, Chung DH, Parekh D, Yoshinaga K, Greeley Jr GH, Uchida T, Townsend Jr CM, Thompson JC 1992 Neurotensin stimulates growth of colonic mucosa in young and aged rats. Gastroenterology 103:86-91
66. Whiteman EL, Cho H, Birnbaum MJ 2002 Role of Akt/protein kinase B in metabolism. Trends Endocrinol Metab 13:444-451
67. Li X, Leu S, Cheong A, Zhang H, Baibakov B, Shih C, Birnbaum MJ, Donowitz M 2004 Akt2, phosphatidylinositol 3-kinase, and PTEN are in lipid rafts of intestinal cells: role in absorption and differentiation. Gastroenterology 126:122-135
68. Ulshen MH, Dowling RH, Fuller CR, Zimmermann EM, Lund PK 1993 Enhanced growth of small bowel in transgenic mice overexpressing bovine growth hormone. Gastroenterology 104:973-980
69. Kim KA, Kakitani M, Zhao J, Oshima T, Tang T, Binnerts M, Liu Y, Boyle B, Park E, Emtage P, Funk WD, Tomizuka K 2005 Mitogenic influence of human R-spondin1 on the intestinal epithelium. Science 309:1256-1259